The Initial Report of Local Control on RTOG 0436: A Phase 3 Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Patients With Esophageal Cancer Treated Without Surgery

Authors :: Andre Konski
David H. Ilson
Bapsi Chakravarthy
Melvin Deutsch
N. Horiba
Howard Safran
Lisa A. Kachnic
V.S. Kavadi
Mohan Suntharalingam
M. Roof
Kathryn Winter
Gregory M.M. Videtic
Harish V. Thakrar
Christopher H. Crane
Adam P. Dicker
J. Pollack
Adam Raben
Christopher J. Anker
Source :: International Journal of Radiation Oncology*Biology*Physics. 90:S3
Publication Year :: 2014
Publisher :: Elsevier BV, 2014.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Radiation
Cetuximab
business.industry
Paclitaxel-cisplatin
Esophageal cancer
medicine.disease
Internal medicine
medicine
Radiology, Nuclear Medicine and imaging
business
medicine.drug

Tools